Table 1.
Authors | Virus | Target Cell | Assay(s) | Total hits | Replication? | Notes |
---|---|---|---|---|---|---|
Brass et al. [1] | A/PR/8/34 | U2OS | immunostaining | 254 | single-cycle | Identified IFITM proteins as potent antiviral restriction factors |
Hao et al. [4] | Flu-VSV-G-Renilla luciferase | DL1 | luciferase assay | ∼84 with obvious human homologues | single-cycle | Initial screens were performed in Drosophila cells using VSV-G psuedotyped reporter virus. Select hits were confirmed in human 293 cells with A/WSN/33 and an H5N1 isolate (A/Indonesia/7/2005). |
Karlas et al. [2] | A/WSN/33 | A549 | immunostaining to measure primary infection, luciferase assay to titer virus yields | 287 | single- and multi-cycle | Many hits were confirmed using a 2009 H1N1 isolate (A/Hamburg/04/2009) and a H5N1 isolate (A/Vietnam/1204/2004). |
König et al. [3] | A/WSN/33-Ren | A549 | live-cell luciferase assay at 12, 24, and 36 h post-infection | 298 | single-cycle | HA coding sequence in the virus was replaced with the Renilla luciferase reporter gene. Many hits were confirmed with a 2009 H1N1 isolate (A/Netherland/602/2009). |
Shapira et al. [5] | A/PR/8/34 (WT and ΔNS1) | HBEC | luciferase assay to titer virus yields | 616 | multi-cycle | Screening included analysis of yeast 2-hybrid, transcriptional profiling, IFN-β production and infection assays. |